Skip to content
Open Menu
Search for:
News & events
Insight & resources
Facilities
Careers
Contact
Drug substance
Back to main menu
Drug substance
Custom development
Process development & validation
Analytical development & validation
Custom manufacturing
Technology transfer
Manufacturing capabilities
Quality & regulatory
Environment, health & safety
Generic APIs
Product catalogue
Controlled substances
High potency APIs
Animal health discovery
Specialist technologies
Biocatalysis
Continuous flow
Controlled substances
Crystallization process development
High potency APIs
Solid state science
Material characterization
Drug product
Back to main menu
Drug product
Custom development
Formulation development
Analytical development & validation
Clinical supply
Custom manufacturing
Technology transfer
Manufacturing capabilities
Quality & regulatory
Environment, health & safety
Packaging
Conventional dosage forms
Solid dose
Semi-solid dose
Liquids
Specialized dosage forms
Fixed-dose combinations
Pediatric
Bi-layer tablets
Stick packs
Topicals
Controlled substances
Sterile & non-sterile
Solid state science
Material characterization
Analytical services
Back to main menu
Analytical services
Compendial testing
Microbiology
Cleanroom services
Release & QC testing
Extractables/leachables studies
Stability storage
Method development & validation
Material characterization
Elemental impurities
Impurity isolation, identification & characterization
Reference standard qualification
Bioanalytical & biopharmaceutical analysis
Open Search
News & events
Search news
Post date
Post Date
Tags
Tags
All Tags
About (2)
analytical services (2)
APIs (5)
biocatalysis (1)
Cambrex (9)
Careers (1)
cGMP (1)
Chemical Molecules (1)
Chemistry (1)
CMO (1)
CMOs (1)
Compounds (1)
Continuous flow (2)
Corporate Brochure (1)
Custom Development (1)
Development (1)
Drug product (5)
Drug substance (9)
Facilities (2)
Finance (1)
HPAPIs (1)
Information Sheets (1)
Literature (5)
Manufacturing (1)
Opioids (1)
Pharmaceutical (1)
Resources (5)
Small Molecule (2)
Video (1)
Webcasts (2)
Webinar (6)
By author
By Author
All Authors
Alex Maw (32)
Cambrex (204)
Lisa Glendinning (1)
Nicola Good (1)
Advanced search
Latest news
Read more
December 4, 2019
Cambrex Announces Completion of Acquisition by the Permira Funds
November 14, 2019
Cambrex Wins Third API Development Award at CPhI Worldwide
October 24, 2019
Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results
September 23, 2019
Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement
August 8, 2019
Cambrex Cancels Second Quarter Earnings Conference Call and Will Not Update Financial Guidance
August 7, 2019
Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash
August 6, 2019
Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019
Read more from our news archive
Skip to content Open Menu